Aaah, back to the normal insults Pledges. "Off chops heh?"...

Aaah, back to the normal insults Pledges. "Off chops heh?" Lacking a "grip" on reality. You are the antithesis poster child for the modern sensitive generation throwing around mental health insults. I am "off chops", for 'insanely' wanting to discuss, the actual subject of this formal ASX news release by CYP, that it achieved a two year survival rate of 9/15 in its "Two-Year Results of Phase 1 SR-aGvHD Trial" to be presented at the forthcoming ISCT conference - where the informed grown ups assemble to discuss such things?

Now I appreciate you didn't like my comment above showing how ridiculously valued CYP vs MSB is, a stock I own myself, but you kind of forced my hand with your personal insults and endless prattling attempts to discuss anything but CYP's preliminary trial success (i.e. the actual subject of this thread), I appreciate its difficult to continue your non-sensical arguments when someone illustrates that MSB, a late stage 3 stem cell company trading at 11.3 times its cash on hand versus, admittedly a less advanced/extensively trialed, but nonetheless FULLY FUNDED late stage 3 stem cell company (fully funded in its stage 3 trial knee OA trial) you are trying to bag (CYP), trades at 1.3 times cash on hand.

"So lets see, MSB has around $79 million cash on hand and a truck load of promising trials on hand with possible FDA, EMA and TGA approval not too far in the future, and trades for $900 million mkt cap. CYP has around $18 million in cash on hand and a truck load of promising trials on hand with possible FDA, EMA and TGA approval a little further in the future, but with arguably superior bio-tech, and trades for $23 million mkt cap. Are you grasping it yet?"

Again, you force my hand every time with your continued personal insults and endless prattling attempts to discuss anything but CYP's preliminary trial success....the subject of this thread.